General Information of the Compound
| Compound ID |
CP0014908
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-(acetylamino)-N-(2-amino-phenyl) benzamide
Show/Hide
|
||||||||||||||||||
| Synonyms |
4-(Acetylamino)-N-(2-aminophenyl)benzamide
4-acetamido-N-(2-aminophenyl)benzamide
4-acetamido-n-(2-aminophenyl)benzamid
4-acetylamino-N-(2'-aminophenyl)benzamide
Acetyldinaline
C.I. 994
Ci-994
Goe 5549
Goe-5549
PD 123654
PD-123654
Tacedinalina
Tacedinalina [INN-Spanish]
Tacedinaline
Tacedinaline (USAN/INN)
Tacedinaline [USAN:INN]
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C15H15N3O2
|
||||||||||||||||||
| Molecular Weight |
269.304
|
||||||||||||||||||
| Canonical SMILES |
CC(=O)Nc1ccc(cc1)C(=O)Nc1ccccc1N
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C15H15N3O2/c1-10(19)17-12-8-6-11(7-9-12)15(20)18-14-5-3-2-4-13(14)16/h2-9H,16H2,1H3,(H,17,19)(H,18,20)
Show/Hide
|
||||||||||||||||||
| InChIKey |
VAZAPHZUAVEOMC-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
112522-64-2
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound